ArticleScientific data2020
Epidemiological data from the COVID-19 outbreak, real-time case information.
Article in Scientific data, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 172 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
172 citing papers in PubMed.
- Multimodal Data Approaches for Examining the 2024-2025 Highly Pathogenic Avian Influenza Outbreak in the United States: Descriptive Study.JMIR public health and surveillance · 2026Article
- Global approaches to infectious disease surveillance and modeling.Nature medicine · 2026Review
- Models for SARS-CoV-2 health policies: social distancing amid vaccination and virus variants.Royal Society open science · 2025Article
- Association Between Pre-Existing Conditions and COVID-19 Hospitalization, Intensive Care Services, and Mortality: A Cross-Sectional Analysis of an International Global Health Data Repository.Pathogens (Basel, Switzerland) · 2025Article
- National consumption of antimicrobials intended for use in animal livestock health: a retrospective data analysis of antimicrobial imports to Uganda from 2018 to 2020.BMC veterinary research · 2025Article
- Review
- Predictive Modeling of Global SARS-CoV-2 Infection Risk in Animals: Unveiling Potential Reservoirs and Informing Health Policy Synergies.Transboundary and emerging diseases · 2025Article
- Unified framework for the ingestion of early epidemic data for downstream data analytics.Wellcome open research · 2025Article
- The Impact of Public Health and Social Measures (PHSMs) on SARS-CoV-2 Transmission in the WHO European Region (2020-2022).Influenza and other respiratory viruses · 2024Article
- Evaluation and comparison of one-step real-time PCR and one-step RT-LAMP methods for detection of SARS-CoV-2.BMC infectious diseases · 2024Article
- Finding influential nodes in complex networks based on Kullback-Leibler model within the neighborhood.Scientific reports · 2024Article
- Hesperidin, a Potential Antiviral Agent against SARS-CoV-2: The Influence of Citrus Consumption on COVID-19 Incidence and Severity in China.Medicina (Kaunas, Lithuania) · 2024Review
- Private Continuous Survival Analysis with Distributed Multi-Site Data.Proceedings : ... IEEE International Conference on Big Data. IEEE International Conference on Big Data · 2023Article
- Using Chaos-Game-Representation for Analysing the SARS-CoV-2 Lineages, Newly Emerging Strains and Recombinants.Current genomics · 2023Article
- An Optimized Model Based on Deep Learning and Gated Recurrent Unit for COVID-19 Death Prediction.Biomimetics (Basel, Switzerland) · 2023Article
- Monitoring the West Nile virus outbreaks in Italy using open access data.Scientific data · 2023Article
- Lessons from COVID-19 for rescalable data collection.The Lancet. Infectious diseases · 2023Review
- Correlation Between Daily PM10, Nitrogen Dioxide, and Ozone Measurements with the Stringency Index in 15 Different Districts of a Big Metropolis.Thoracic research and practice · 2023Article
- Unified real-time environmental-epidemiological data for multiscale modeling of the COVID-19 pandemic.Scientific data · 2023Article
- Innovative platforms for data aggregation, linkage and analysis in the context of pandemic and epidemic intelligence.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023Article
112 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cases of a novel coronavirus were first reported in Wuhan, Hubei province, China, in December 2019 and have since spread across the world. Epidemiological studies have indicated human-to-human transmission in China and elsewhere. To aid the analysis and tracking of the COVID-19 epidemic we collected and curated individual-level data from national, provincial, and municipal health reports, as well as additional information from online reports. All data are geo-coded and, where available, include symptoms, key dates (date of onset, admission, and confirmation), and travel history. The generation of detailed, real-time, and robust data for emerging disease outbreaks is important and can help to generate robust evidence that will support and inform public health decision making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.